Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SanBio CoTSE:4592 -3.07%23 Gross Margin % is 0.00% as of Jan. 2026. GuruFocus rates TSE:4592 with a GF Score™ of 23/100. The stock has 1 warning sign investors should review. Among 735 Biotechnology companies, SanBio Co ranks worse than 136054.29% on this metric.
The historical rank and industry rank for SanBio Co's Gross Margin % or its related term are showing as below:
During the past 13 years, the highestGross Margin % of SanBio Co was 98.19%. The lowest was 98.19%. And the median was 98.19%.
TSE:4592's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 60.96 * Ranked among companies with meaningful Gross Margin % only.
SanBio Co had a gross margin of N/A% for the quarter that ended in Jan. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for SanBio Co was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
SanBio Co had a gross margin of N/A% for the quarter that ended in Jan. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
SanBio Co Gross Margin % Related Terms
SanBio Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for SanBio Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4592 vs VRTX, REGN, RVMD: Gross Margin % Comparison
For the Biotechnology subindustry, SanBio Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SanBio Co Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, SanBio Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where SanBio Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
SanBio Co (TSE:4592) has a Gross Margin % of 0.00% as of Jan. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on SanBio Co and its competitors. Over the past decade, SanBio Co's Gross Margin % has ranged from 98.19 to 98.19. According to the industry distribution chart, SanBio Co ranks #999999 out of 735 companies in the Biotechnology industry.
Is SanBio Co's Gross Margin % too high?
SanBio Co's current Gross Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 98.19 to a high of 98.19. Based on the distribution chart, SanBio Co ranks #999999 out of 735 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, SanBio Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does SanBio Co's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, SanBio Co ranks #999999 out of 735 companies for Gross Margin %. This places SanBio Co in the lower half of its industry. The industry median Gross Margin % is 60.96. Historically, SanBio Co's own Gross Margin % has ranged from 98.19 to 98.19 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.96, based on 735 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on SanBio Co and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SanBio Co's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SanBio Co stock overvalued right now?
SanBio Co (TSE:4592) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. SanBio Co's overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For SanBio Co (TSE:4592), the current Gross Margin % is 0.00% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.
23GF Score
Get the complete analysis for TSE:4592
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4592 has been successfully added to your 
